Description
Manufacturer
GLAXOSMITHKLINE BIOLOGICALS S.A(BELGIUM)
Registraction Number
MAL24086007ARZ
Contents
Active Ingredient: Recombinant Respiratory Syncytial Virus (RSV) pre-fusion F protein (RSVPreF3), 120 micrograms per dose.
Adjuvant System: AS01E, which includes:
Quillaja saponaria saponin (QS-21): 25 micrograms.
- O-desacyl-4'-monophosphoryl lipid A (MPL): 25 micrograms.
Indications
Arexvy is used for:
Active immunization to prevent lower respiratory tract disease caused by RSV in:
Adults aged 60 years and older.
Adults aged 50–59 years at increased risk for RSV disease.
Instructions
Dosage: Administered as a single dose of 0.5 mL.
Administration: Intramuscular injection, preferably in the deltoid muscle.
Preparation: The vaccine must be reconstituted before use. The powder and suspension are mixed to form an opalescent, colorless to pale brownish liquid.
Storage: Store in a refrigerator (2–8°C). Do not freeze. Use the reconstituted vaccine promptly or within 4 hours if stored at room temperature.
More detail about Complete Wellness
Malaysia
